Royal Bank of Canada’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
21,857
+6,303
| +41% | +$298K | ﹤0.01% | 3562 |
|
|
2025
Q1 | $608K | Sell |
15,554
-341
| -2% | -$13.3K | ﹤0.01% | 3521 |
|
|
2024
Q4 | $861K | Buy |
15,895
+1,343
| +9% | +$72.7K | ﹤0.01% | 3264 |
|
|
2024
Q3 | $733K | Sell |
14,552
-3,284
| -18% | -$165K | ﹤0.01% | 3390 |
|
|
2024
Q2 | $784K | Sell |
17,836
-79,638
| -82% | -$3.5M | ﹤0.01% | 3302 |
|
|
2024
Q1 | $4.9M | Buy |
97,474
+70,686
| +264% | +$3.55M | ﹤0.01% | 1946 |
|
|
2023
Q4 | $1.62M | Buy |
26,788
+2,705
| +11% | +$163K | ﹤0.01% | 2793 |
|
|
2023
Q3 | $1.37M | Buy |
24,083
+3,887
| +19% | +$222K | ﹤0.01% | 2758 |
|
|
2023
Q2 | $1.03M | Buy |
20,196
+19,540
| +2,979% | +$997K | ﹤0.01% | 2984 |
|
|
2023
Q1 | $14K | Buy |
656
+580
| +763% | +$12.4K | ﹤0.01% | 5784 |
|
|
2022
Q4 | $1K | Buy |
+76
| New | +$1K | ﹤0.01% | 6576 |
|